• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[老年前列腺癌手术治疗的局限性?]

[Limits of surgical therapy of prostate cancer in the aged?].

作者信息

Schultze-Seemann W

机构信息

Urologische Abteilung, Chirurgische Klinik der Universität Freiburg/Br.

出版信息

Fortschr Med. 1993 Jul 20;111(20-21):343-6.

PMID:8375788
Abstract

The incidence of carcinoma of the prostate is increasing throughout the entire western world. The general rise in life expectancy is associated with the fact that many of these carcinomas of old age are now becoming clinically relevant. For curative treatment of prostate carcinoma, three procedures are available (radical prostatectomy, brachytherapy, radiotherapy). In terms of local freedom from tumor and long-term survival, radical prostatectomy is superior to the other modalities. Since improvements in our knowledge of the relevant anatomy have considerably reduced surgical morbidity and mortality, the procedure represents standard treatment in patients with a statistical life expectancy of at least 10 years and locally limited carcinoma of the prostate.

摘要

在整个西方世界,前列腺癌的发病率都在上升。预期寿命的普遍提高与这样一个事实有关,即许多老年前列腺癌目前正变得具有临床相关性。对于前列腺癌的根治性治疗,有三种方法可供选择(根治性前列腺切除术、近距离放射疗法、放射疗法)。就局部无瘤和长期生存而言,根治性前列腺切除术优于其他方法。由于我们对相关解剖学知识的改进已大大降低了手术发病率和死亡率,该手术是预期统计寿命至少为10年且前列腺癌局部局限的患者的标准治疗方法。

相似文献

1
[Limits of surgical therapy of prostate cancer in the aged?].[老年前列腺癌手术治疗的局限性?]
Fortschr Med. 1993 Jul 20;111(20-21):343-6.
2
[Surgical therapy of locally confined prostate carcinoma].[局限性前列腺癌的手术治疗]
Praxis (Bern 1994). 1997 Nov 12;86(46):1819-24.
3
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.自前列腺特异性抗原检测出现以来,针对临床晚期(cT3)前列腺癌的根治性前列腺切除术:15年的结果。
BJU Int. 2005 Apr;95(6):751-6. doi: 10.1111/j.1464-410X.2005.05394.x.
4
[The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].[采用根治性前列腺切除术或放射疗法治疗局部晚期(T3期)前列腺癌。综述]
Tijdschr Gerontol Geriatr. 1998 Apr;29(2):74-9.
5
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.根据临床Gleason评分和患者年龄,对临床非转移性前列腺腺癌根治性前列腺切除术后的竞争风险分析。
J Urol. 2002 Aug;168(2):525-9.
6
[Do results of surgical treatment of cancer clinically localized to the prostate justify early screening?].[临床局限于前列腺的癌症手术治疗结果能否证明早期筛查是合理的?]
Praxis (Bern 1994). 1997 Oct 29;86(44):1730-3.
7
Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate.前列腺临床分期为T3腺癌的原发性手术治疗。
Semin Urol Oncol. 1997 Nov;15(4):215-21.
8
[The role of radical prostatectomy in cT3 prostate carcinoma].
Praxis (Bern 1994). 2001 Sep 20;90(38):1623-31.
9
[Clinical relevance of incidental prostate carcinoma. A retrospective study].[偶发性前列腺癌的临床相关性。一项回顾性研究]
Urologe A. 1996 Jul;35(4):315-20.
10
Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.放射治疗后复发性前列腺癌的挽救性根治性前列腺切除术。
Int J Urol. 2009 Jun;16(6):584-6. doi: 10.1111/j.1442-2042.2008.02209.x. Epub 2009 Apr 22.